Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Diabetes and COVID-19: IDF perspective in the Western Pacific Region
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
Diabetes and COVID-19: IDF perspective in the Western Pacific Region
Creator
Jia, W
Huang, C-N
Huang, Chien-Ning
Hwang, Y
Hwang, Yerin
Jenkins, A
Jenkins, Alicia
Jia, Weiping
Kadowaki, T
Kadowaki, Takashi
Khasag, A
Khasag, Altaisaikhan
Kim, D-M
Kim, Doo-Man
Lee, M-K
Lee, Moon-Kyu
Yabe, D
Yabe, Daisuke
source
Elsevier; Medline; PMC
abstract
Abstract The World Health Organization (WHO) declared a pandemic, the highest risk level in the infectious disease alert phase, on 11 March 2020. In the Western Pacific Region (WPR), 192,016 confirmed cases with 7,125 deaths had been reported as of 8 June 2020. In people with diabetes COVID-19 can be more difficult to treat due to the wide fluctuations in blood glucose levels or presence of comorbidities such as diabetes complications, including cardiovascular disease and renal damage, which are recognized risks for adverse outcomes. National diabetes associations and governments have established guidelines for subjects with diabetes in relation to COVID-19, and are trying to supply emergency and their regularly required medical products for them. The WPR is so large and composed of such diverse countries and COVID-19 situations, no one conclusion or program applies. Instead we could see a diverse COVID-19 pandemic profile in the WPR, and several creative diagnostic and therapeutic measures undertaken. This includes drive-through screening facilities, high-speed RT-PCR technologies, convalescent patients’ plasma therapy, which potentially had some positive contributions in combatting COVID-19 in the WPR as well as globally. Although the numbers of confirmed cases are currently decreasing in the region, the COVID-19 pandemic is not over, and many experts are recommending to prepare measures for potential second or third waves of COVID-19.
has issue date
2020-06-25
(
xsd:dateTime
)
bibo:doi
10.1016/j.diabres.2020.108278
bibo:pmid
32592842
has license
els-covid
sha1sum (hex)
282b4c8485ff9211559581373584ec499c10a2d7
schema:url
https://doi.org/10.1016/j.diabres.2020.108278
resource representing a document's title
Diabetes and COVID-19: IDF perspective in the Western Pacific Region
has PubMed Central identifier
PMC7314686
has PubMed identifier
32592842
schema:publication
Diabetes Res Clin Pract
resource representing a document's body
covid:282b4c8485ff9211559581373584ec499c10a2d7#body_text
is
schema:about
of
named entity 'phase'
named entity 'WHO'
named entity 'Diabetes'
named entity 'COVID-19'
named entity 'ventilator'
named entity 'epidemic'
named entity 'diabetic'
named entity 'medical staff'
named entity 'Philippines'
named entity 'China'
named entity 'health professionals'
named entity 'Central Epidemic Command Center'
named entity 'COVID-19'
named entity 'diabetes'
named entity 'Type 1 diabetes'
named entity 'alcohol'
named entity 'social and economic'
named entity 'elective procedures'
named entity '7,000'
named entity 'diabetes'
named entity 'RT-PCR'
named entity 'lag phase'
named entity '8,000'
named entity 'people with diabetes'
named entity 'COVID'
named entity 'glycemic control'
named entity 'drive-through'
named entity 'China'
named entity 'COVID-19'
named entity 'COVID-19'
named entity 'self-care'
named entity 'healthcare providers'
named entity 'virus'
named entity 'COVID-19 outbreak'
named entity 'COVID'
named entity 'people with diabetes'
named entity 'COVID-19'
named entity 'Hong Kong'
named entity 'treatment of patients'
named entity 'COVID'
named entity 'COVID-19'
named entity 'Taiwan'
named entity 'pediatric endocrinology'
named entity 'infectious agents'
named entity 'gowning'
named entity 'COVIDSafe'
named entity 'prevent the spread'
named entity 'Gyeongsangbuk-do'
named entity 'Australia'
named entity 'coronavirus'
named entity 'COVID-19'
named entity 'COVID-19'
named entity 'plasma'
named entity 'antibody test'
named entity 'Wuhan'
named entity 'research results'
named entity 'video conference'
named entity 'state of emergency'
named entity 'current situation'
named entity 'infectious diseases'
named entity 'COVID-19 pandemic'
named entity 'COVID'
named entity '7,500'
named entity 'people with diabetes'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 4
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software